Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas
Authors
Keywords
-
Journal
NEUROSURGERY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-04-06
DOI
10.1093/neuros/nyz125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation
- (2018) Sylvain Gioux et al. Molecular Imaging
- Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent
- (2017) Julia Parrish-Novak et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- TRTH-12. PHASE 1 SAFETY, PHARMACOKINETIC AND IMAGING STUDY OF BLZ-100 TUMOR PAINT IN PEDIATRIC BRAIN TUMOR PATIENTS
- (2017) Amy Lee et al. NEURO-ONCOLOGY
- Chlorotoxin: Structure, activity, and potential uses in cancer therapy
- (2016) Paola G. Ojeda et al. BIOPOLYMERS
- Technical principles in glioma surgery and preoperative considerations
- (2016) Daria Krivosheya et al. JOURNAL OF NEURO-ONCOLOGY
- Intraoperative Near-Infrared Optical Imaging Can Localize Gadolinium-Enhancing Gliomas During Surgery
- (2016) John Y.K. Lee et al. NEUROSURGERY
- Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate
- (2016) Fred M. Baik et al. JAMA Otolaryngology-Head & Neck Surgery
- Association of the Extent of Resection With Survival in Glioblastoma
- (2016) Timothy J. Brown et al. JAMA Oncology
- Image-Guided Tumor Resection
- (2015) Julia Parrish-Novak et al. CANCER JOURNAL
- Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
- (2015) J. Fidel et al. CANCER RESEARCH
- Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection
- (2015) Florian Ringel et al. NEURO-ONCOLOGY
- Intraoperative brain cancer detection with Raman spectroscopy in humans
- (2015) Michael Jermyn et al. Science Translational Medicine
- Chlorotoxin: A Helpful Natural Scorpion Peptide to Diagnose Glioma and Fight Tumor Invasion
- (2015) Lucie Dardevet et al. Toxins
- Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors
- (2014) Pramod V. Butte et al. Neurosurgical Focus
- Characterization of IRDye 800CW chlorotoxin as a targeting agent for brain tumors
- (2013) Joy L. Kovar et al. ANALYTICAL BIOCHEMISTRY
- Risk factors and outcomes associated with surgical site infections after craniotomy or craniectomy
- (2013) Hsiu-Yin Chiang et al. JOURNAL OF NEUROSURGERY
- In Vivo Bio-imaging Using Chlorotoxin-based Conjugates
- (2012) Mark R. Stroud et al. CURRENT PHARMACEUTICAL DESIGN
- An Experimental Study to Evaluate the Fluobeam 800 Imaging System for Fluorescence-Guided Lymphatic Imaging and Sentinel Node Biopsy
- (2012) Christoph Hirche et al. Surgical Innovation
- Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects
- (2009) Kamala Kesavan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
- (2008) Justin S. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells
- (2008) Hemant Sarin et al. Journal of Translational Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More